Clinical Trial

Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-22.
Trial Details
NCT Number NCT06848946
Lead Sponsor Glaukos Corporation
Conditions Glaucoma, Open-angle, Ocular Hypertension (OHT), Phacoemulsification Cataract Surgery
Enrollment 132 participants
Start Date 2025-01-13
Primary Completion 2026-08 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-21